|
Terminated
|
NCT03309358 -
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
|
Phase 1 |
|
Recruiting
|
NCT02922998 -
CD64 and Antibiotics in Human Sepsis
|
N/A |
|
Completed
|
NCT04212403 -
Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)
|
N/A |
|
Recruiting
|
NCT05502380 -
Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
|
Phase 3 |
|
Withdrawn
|
NCT04462133 -
Optimal Tailored Treatment for H. Pylori Infection
|
N/A |
|
Completed
|
NCT03535324 -
Opportunities for Antibiotic Optimisation and Outcomes Improvement in Patients With Negative Blood Culture (NO-BACT)
|
N/A |
|
Recruiting
|
NCT05950984 -
Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)
|
|
|
Withdrawn
|
NCT04230746 -
Effect of Antibiotics on Urinary Microbiome
|
Early Phase 1 |
|
Active, not recruiting
|
NCT03865706 -
Inulin for Infections in the Intensive Care Unit
|
Phase 2 |
|
Not yet recruiting
|
NCT06028217 -
Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment
|
|
|
Completed
|
NCT05391035 -
The Antibiotic Guardian Study- Clinical Evaluation of a Novel, Rapid Diagnostic for Gonorrhoea and Mycoplasma Infections.
|
|
|
Recruiting
|
NCT05224401 -
Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs
|
Phase 3 |
|
Not yet recruiting
|
NCT03855709 -
Antibiotic-resistant Bacterial Infection of Hepatic Patients
|
|
|
Terminated
|
NCT03535272 -
Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea
|
Phase 3 |
|
Recruiting
|
NCT05902299 -
Evaluation of the Impact of the Modification of Antibiotic Susceptibility Testing on Antibiotic Prescriptions
|
|
|
Recruiting
|
NCT05293483 -
The Impact of Covid-19 Hospital Care on the Prevalence of MDRO in Indonesia
|
|
|
Recruiting
|
NCT05561504 -
Helicobacter Pylori Local Prevalence and Antibiotic Resistance
|
|
|
Recruiting
|
NCT03606031 -
Digestive Microbiota Transplant
|
|
|
Completed
|
NCT01573195 -
Merck IISP Stewardship Grant for Antibiotic Best Practices
|
Phase 4 |
|
Not yet recruiting
|
NCT03857295 -
Infections Following NeuroSurgery (INS)
|
|